We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Screening Patients’ Tumor Tissues May Reveal Which Cancer Drugs Will Work Best
News

Screening Patients’ Tumor Tissues May Reveal Which Cancer Drugs Will Work Best

Screening Patients’ Tumor Tissues May Reveal Which Cancer Drugs Will Work Best
News

Screening Patients’ Tumor Tissues May Reveal Which Cancer Drugs Will Work Best

Credit: Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Screening Patients’ Tumor Tissues May Reveal Which Cancer Drugs Will Work Best"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genetic differences can affect the susceptibility of cancer cells to different drugs. In a new Molecular Oncology study, investigators show that surgically-removed breast and prostate tumor specimens can be used to rapidly screen different drugs to see which ones most effectively target an individual’s cancer cells.

The ability to quickly evaluate drug efficacy in patient-derived material in this way may help in the design of personalized medicine approaches against cancer.

“The information we get from testing cancer drugs on actual human tumors has potential to advance cancer research in unprecedented ways, from improved diagnostic and prognostic tools to better drug screening and design, and of course, tailoring treatments to individual patients,” said lead author Dr. Margaret Centenera, of the University of Adelaide, in Australia.

This article has been republished from materials provided by Wiley. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference
Centenera, M.M., et al. A patient‐derived explant (PDE) model of hormone‐dependent cancer. Mol Oncol. 2018 Aug 16. doi: 10.1002/1878-0261

Advertisement